Accelmed Partners II Acquires TearLab Corporation

Bausch + Lomb Acquires Trukera Medical

July 23, 2024

Medical Devices

Bausch + Lomb Corporation announced that an affiliate has acquired Trukera Medical (formerly TearLab) from private equity owner AccelMed Partners and other shareholders. The tuck‑in acquisition brings the ScoutPro point‑of‑care tear osmolarity diagnostic into Bausch + Lomb’s surgical portfolio to strengthen preoperative dry eye assessment and expand its U.S. surgical presence.

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.

AccelLAB Management Acquires AccelLAB from Charles River Laboratories

January 18, 2024

Medical Devices

Key members of AccelLAB's management team acquired AccelLAB from Charles River Laboratories, and the business will operate independently as a standalone preclinical CRO serving the medical device and biologics markets. Fairmount Partners served as exclusive financial advisor to Charles River in the divestiture; AccelLAB employs approximately 100 staff across facilities in Boisbriand and Terrebonne, Quebec, Canada.

3M Acquires Acelity (and KCI) from Apax-led Consortium for $6.725B

October 11, 2019

Medical Devices

3M has completed the acquisition of Acelity and its KCI subsidiaries from funds advised by Apax Partners and consortium partners Canada Pension Plan Investment Board and the Public Sector Pension Investment Board for $6.725 billion. The transaction transfers Acelity — a global leader in advanced wound care and negative pressure wound therapy headquartered in San Antonio — to 3M, expanding 3M’s medical products capabilities.

TEAM Technologies (Clearlake-backed) Acquires iiMED Medical Solutions from ACON Investments

January 12, 2022

Medical Devices

TEAM Technologies, a Clearlake Capital-backed specialty manufacturer, has acquired iiMED Medical Solutions from ACON Investments. iiMED is a nearshore manufacturer of FDA Class I & II consumable medical devices based in Amherst, New York with manufacturing in Reynosa, Mexico; the deal expands TEAM's medical device manufacturing capabilities and nearshore footprint. Financial terms were not disclosed.

Ampersand Capital Partners Recapitalizes American Laboratory Products Company (ALPCO)

September 21, 2020

Medical Devices

Ampersand Capital Partners completed a majority recapitalization of American Laboratory Products Company (ALPCO) to provide growth capital for expanding ALPCO's diagnostics test kit offering, geographic reach, and R&D/production capabilities. Founders Richard and Jan Conley will remain shareholders, Sean Conley will continue as CEO, and Larry McCarthy, PhD was named Board Chairman.